•  
  •  
 

Abstract

Daptomycin-induced eosinophilic pneumonia (DIEP) is a rare, underreported adverse medication event with an incidence rate of 1.7% that has been linked to severe pulmonary toxicity and respiratory distress. Here, we present a less common case of a female in her 80s treated at a community hospital with a six-week course of daptomycin for a sacral ulcer, who presented with a dry cough, dyspnea, and crackles at both lung bases on exam. Her labs were significant for eosinophilia, and imaging revealed bilateral ground-glass infiltrates and small pleural effusions, representing infectious pneumonia. Given the patient’s daptomycin therapy, a diagnosis of daptomycin-induced eosinophilic pneumonia was established. Upon daptomycin withdrawal and steroid treatment, the patient’s clinical symptoms rapidly improved. This case highlights the critical importance of early recognition and detection of this rare adverse drug event in order to improve patient prognosis.

DOI

10.55729/2000-9666.1673

Share

COinS